KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Long-Term Investments (2016 - 2025)

Humana (HUM) has disclosed Long-Term Investments for 16 consecutive years, with $623.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Investments changed N/A to $623.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $623.0 million, a N/A change, with the full-year FY2022 number at $380.0 million, down 51.28% from a year prior.
  • Long-Term Investments was $623.0 million for Q3 2025 at Humana, down from $636.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $13.5 billion in Q3 2022 to a low of $143.0 million in Q3 2021.
  • A 4-year average of $1.5 billion and a median of $647.5 million in 2025 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: crashed 98.97% in 2021, then surged 9339.86% in 2022.
  • Humana's Long-Term Investments stood at $780.0 million in 2021, then plummeted by 51.28% to $380.0 million in 2022, then fell by 2.63% to $370.0 million in 2023, then skyrocketed by 68.38% to $623.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Long-Term Investments are $623.0 million (Q3 2025), $636.0 million (Q2 2025), and $659.0 million (Q1 2025).